Navigation Links
NxStage Medical Announces Needle Supply Agreement with DaVita
Date:1/7/2008

ence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the Company's website at http://www.nxstage.com.

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including, but not limited to, changes relating to customer demand for NxStage's needle and other products and other factors that are discussed in NxStage's filings with the Securities and Exchange Commission, including the Quarterly Report on Form 10-Q for the quarter ended September 30, 2007. NxStage is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.

CONTACT:

Stephanie Marks of NxStage Medical, Inc.,

1-888-698-6472, ir@nxstage.com

Web site: http://www.nxstage.com


'/>"/>
SOURCE NxStage Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. NxStage Medical to Present at the Piper Jaffray Healthcare Conference on November 27, 2007
2. Arbios Announces SEPET(TM) Manufacturing Agreement With NxStage Medical
3. NxStage(R) Medical to Report Third Quarter 2007 Financial Results on Friday, November 2nd
4. NxStage Medical Provides Update on Medisystems Acquisition
5. NxStage Medical to Present at the Thomas Weisel Partners Healthcare Conference on September 5, 2007
6. Romark Laboratories Names Emmet B. Keeffe, M.D. Vice President and Chief Medical Officer
7. Triage study challenges notions of emergency medical response to disaster
8. Chimerix Appoints Neil Frazer, M.B., Ch.B., FRCA, FFPM as Chief Medical Officer
9. Arizona Pain Society and Dr. Robert Barkin, Rush University Medical Center, Present Program on Comprehensive Urine Drug Testing Sponsored by Dominion Diagnostics
10. Inverness Medical Innovations to Participate at JP Morgan Healthcare Conference on January 8, 2008
11. Inverness Medical Innovations Acquires ParadigmHealth

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...stCall/ -- Dendreon Corporation (Nasdaq: DNDN ) t...tration (FDA) provided written acknowledgement tha...ion (BLA) for PROVENGE® (sipuleucel-T) is a c...tion Drug User Fee Act (PDUFA) date of May 1, 2010...ded BLA. Dendreon is seeking licensure for PROVEN...
(Date:11/20/2009)...ently announced that Dr. Dominique Hebrault will p...Analytical Technology (PAT) in Green Chemistry and... (PRWEB) November 20, 2009 ...nology (PAT) in Green Chemistry and Green Engineer...hnology (PAT) case studies will be presented on ho...
(Date:11/19/2009)...9 Spherix Incorporated (... diabetes therapy, and a provider of technical and...t, biotechnology and pharmaceutical companies, ann...3 million registered direct placement to instituti...tock and warrants to purchase up to 1,104,348 addi...
(Date:11/19/2009)...Aegera Therapeutics Inc. announced today the dosin...udy of AEG35156, a targeted antisense therapeutic ...ications. ,, The study, entitled "An Open-Label...r of Apoptosis (XIAP) Antisense AEG35156 Given in ...in in AML Following Failure of a Single Standard D...
Breaking Biology Technology:Dendreon Receives FDA Acknowledgement of Complete Response 2Dendreon Receives FDA Acknowledgement of Complete Response 3Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2
...gae is a livid green giveaway of nutrient pollutio...at action in tiny particles that would turn differ...spoilage or signs of poor health in the blood. , ... have tapped the working parts of cells to clear a...eat, which signifies a new approach to technology ...
... N-Viro International Corporation,(OTC Bulletin B...ing company,that owns patented technologies to con...ative fuel products, announces its renewable biofu...elines set forth by the U.S.,Environmental Protect...gy,source that may be utilized in commercial power...
...vania and REHOVOT Israel, January 16, Rosetta Geno...y unveiled initial data relating to the company,s,...creen(TM) colon, which is,based on a simple blood ...e,company,s scientists and collaborators have iden...e potential to accurately differentiate colorectal...
Other Biology Technology:Researchers: Molecular forklifts overcome obstacle to 'smart dust' 2Researchers: Molecular forklifts overcome obstacle to 'smart dust' 3N-Viro Fuel Technology Receives Alternative Energy Status From the U.S. Environmental Protection Agency 2N-Viro Fuel Technology Receives Alternative Energy Status From the U.S. Environmental Protection Agency 3N-Viro Fuel Technology Receives Alternative Energy Status From the U.S. Environmental Protection Agency 4Rosetta Genomics and Collaborators Unveil Colon Cancer Screening Diagnostic; Identified Candidate MicroRNA Biomarkers in Serum 2Rosetta Genomics and Collaborators Unveil Colon Cancer Screening Diagnostic; Identified Candidate MicroRNA Biomarkers in Serum 3Rosetta Genomics and Collaborators Unveil Colon Cancer Screening Diagnostic; Identified Candidate MicroRNA Biomarkers in Serum 4
(Date:11/20/2009)...ass from the production of flax shives, and genera...ant related to those which engulf fields in spring... suggested by two studies carried out by Spanish a... Renewable and Sustainable Energy Reviews . , "Th...of view, the production of bioethanol from two, as...
(Date:11/19/2009)...ghly 15,000 years ago, at the end of the last ice ...als including such iconic creatures as mammoths, ... beavers began their precipitous slide to extinct...ing a land whose diversity of large animals equale...ains then or now, an entirely novel ecosystem emer...
(Date:11/19/2009)...ng Harbor, NY A four-year, multi-institutional ef... (CSHL) scientists culminated today in publication...ience revealing in unprecedented detail the DNA s...it is commonly called by North American consumers,...he most valuable agricultural crop grown in the Un...
Breaking Biology News(10 mins):Flax and yellow flowers can produce bioethanol 2After mastodons and mammoths, a transformed landscape 2After mastodons and mammoths, a transformed landscape 3Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 2Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 3Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 4Florida Hospital Cardiovascular Institute Completes House Wide Implementation of the LifeSync 28R 29 Wireless ECG System 47699 1Florida Hospital Cardiovascular Institute Completes House Wide Implementation of the LifeSync 28R 29 Wireless ECG System 47699 2Florida Hospital Cardiovascular Institute Completes House Wide Implementation of the LifeSync 28R 29 Wireless ECG System 47699 3Understand ARRA Spending Allocations with HIMSS Analytics 26amp 3B 238482 3B Market Intelligence 47698 1Understand ARRA Spending Allocations with HIMSS Analytics 26amp 3B 238482 3B Market Intelligence 47698 2Understand ARRA Spending Allocations with HIMSS Analytics 26amp 3B 238482 3B Market Intelligence 47698 3Dr Erika Says Newsweek 26apos 3Bs Attack on Oprah Ignores the Many Benefits of Her Health Care Advocacy 47696 1Dr Erika Says Newsweek 26apos 3Bs Attack on Oprah Ignores the Many Benefits of Her Health Care Advocacy 47696 2
...anotechnology, researchers are continually on the ... and discovery to scales much smaller than the tin... at Arizona State University, researchers are usin...g at this scale holds great potential for advancin...thought of as the molecule of life, is an ideal bu...
...at Cold Spring Harbor Laboratory have for the firs...ary glands of mice to grow even after birth. They ...these cells are distinct from those that fuel the ...s suggest a novel way that the hormone-secreting g... traumatic stress or to normal life changes like p...
...inal pigment epithelial (RPE) cells attached to ti...in can improve the symptoms of patients with moder...niversity Medical Center neurosurgeon Dr. Roy A. E...nta found the therapy Spheramine was well-tolerate...nian symptoms (tremor, rigidity, slowness of movem...
Other Biology News:Scientists make chemical cousin of DNA for use as new nanotechnology building block 2Scientists make chemical cousin of DNA for use as new nanotechnology building block 3Scientists find stem cells for the first time in the pituitary 2Scientists find stem cells for the first time in the pituitary 3Cell-based therapy shows promise in patients with Parkinson's disease 2Cell-based therapy shows promise in patients with Parkinson's disease 3
Mouse Anti-Human Actopaxin, phospho (Ser8) Monoclonal Antibody, Unconjugated, Clone J160-366 from BD Biosciences Pharmingen
Anti-gp64 Antibody, Unconjugated from Novagen
Rabbit Anti-b-Catenin, phospho (Ser675) Antibody, Unconjugated from Spring Bioscience
Rabbit Anti-Human Naked1 Polyclonal Antibody, Unconjugated from Cell Signaling Technology
Biology Products: